| BRAFi | BRAF V600 inhibitor |
| MEKi | MEK inhibitor |
| ATB | Antibiotic |
| ICI | Immune checkpoint inhibitor |
| ORR | Overall response rate |
| PFS | Progression-free survival |
| mPFS | Median progression-free survival |
| OS | Overall survival |
| mOS | Median overall survival |
| HR | Hazard ratio |
| CI | Confidence interval |
| BMT | Bone marrow transplantation |
| CAR-T | Chimeric antigen receptor T-cell therapy |
| NSCLC | Non–small cell lung cancer |
| RCC | Renal cell carcinoma |